Abbott Labs Spinoff Looks Like the Right Move Investorplace.com Also in development is daclizumab, which appears to be both safe and effective in treating the most common form of multiple sclerosis. Phase III testing is also underway for bardoxolone, which is the first and only drug so far to show the potential to ... |
